Indranil Banerjee

1.1k total citations
31 papers, 892 citations indexed

About

Indranil Banerjee is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Indranil Banerjee has authored 31 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Indranil Banerjee's work include Radiopharmaceutical Chemistry and Applications (6 papers), RNA Interference and Gene Delivery (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Indranil Banerjee is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), RNA Interference and Gene Delivery (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Indranil Banerjee collaborates with scholars based in India, United States and Portugal. Indranil Banerjee's co-authors include Mahitosh Mandal, Subhayan Das, Bikash Chandra Jena, Chandan Kanta Das, Aditya Parekh, Sujit K. Bhutia, Chandan Das, Mridula Misra, Goutam Dey and Kakali De and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Acta Biomaterialia.

In The Last Decade

Indranil Banerjee

30 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indranil Banerjee India 17 576 219 159 144 134 31 892
Thangirala Sudha United States 23 655 1.1× 177 0.8× 129 0.8× 111 0.8× 214 1.6× 46 1.2k
Anabel Sorolla Spain 22 791 1.4× 187 0.9× 140 0.9× 144 1.0× 262 2.0× 49 1.3k
Ying Xie China 17 621 1.1× 181 0.8× 290 1.8× 216 1.5× 113 0.8× 55 1.1k
Abdullah Farooque India 13 332 0.6× 131 0.6× 204 1.3× 164 1.1× 156 1.2× 20 878
Longzhu Piao United States 18 473 0.8× 152 0.7× 194 1.2× 97 0.7× 132 1.0× 25 863
Leiming Xu China 17 362 0.6× 196 0.9× 125 0.8× 258 1.8× 193 1.4× 43 1.0k
Sanam Sadreddini Iran 16 734 1.3× 366 1.7× 150 0.9× 138 1.0× 281 2.1× 25 1.4k
Yong-Qiu Mao China 20 596 1.0× 177 0.8× 119 0.7× 63 0.4× 213 1.6× 50 1.1k
Lili He China 17 689 1.2× 396 1.8× 185 1.2× 155 1.1× 131 1.0× 39 1.2k

Countries citing papers authored by Indranil Banerjee

Since Specialization
Citations

This map shows the geographic impact of Indranil Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indranil Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indranil Banerjee more than expected).

Fields of papers citing papers by Indranil Banerjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indranil Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indranil Banerjee. The network helps show where Indranil Banerjee may publish in the future.

Co-authorship network of co-authors of Indranil Banerjee

This figure shows the co-authorship network connecting the top 25 collaborators of Indranil Banerjee. A scholar is included among the top collaborators of Indranil Banerjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indranil Banerjee. Indranil Banerjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samanta, Dipanjan, Ranabir Majumder, Indranil Banerjee, et al.. (2025). Modified PAMAM Dendrimer-Based Carboplatin Delivery in Glioblastoma: In Vitro and In Vivo Studies. ACS Applied Bio Materials. 8(11). 10393–10404.
2.
Banerjee, Indranil, et al.. (2025). Effective approaches in conquering chemoresistance of glioblastoma: potential for nanoformulations. Drug Delivery and Translational Research. 16(3). 960–982. 1 indexed citations
3.
Das, Subhayan, Moumita Kundu, Aditya Parekh, et al.. (2023). A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(6). 166702–166702. 6 indexed citations
4.
Mendoza, Rachel G., et al.. (2022). Mouse Bone Marrow Cell Isolation and Macrophage Differentiation. Methods in molecular biology. 2455. 85–91. 22 indexed citations
5.
Biswas, Angana, Y. Rajesh, Subhayan Das, et al.. (2022). Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma. Cancer Letters. 544. 215811–215811. 8 indexed citations
6.
Jena, Bikash Chandra, Chandan Kanta Das, Indranil Banerjee, et al.. (2022). TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation. Experimental Cell Research. 417(1). 113195–113195. 36 indexed citations
7.
Banerjee, Indranil, Paul B. Fisher, & Devanand Sarkar. (2021). Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC). Advances in cancer research. 152. 329–381. 7 indexed citations
8.
Jena, Bikash Chandra, Chandan Kanta Das, Indranil Banerjee, et al.. (2021). Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway. Biochemical Pharmacology. 186. 114474–114474. 41 indexed citations
9.
Asad, Mohammad, et al.. (2020). Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model. Cancer Immunology Immunotherapy. 69(9). 1725–1735. 16 indexed citations
10.
11.
Das, Chandan Kanta, Indranil Banerjee, & Mahitosh Mandal. (2019). Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer. Seminars in Cancer Biology. 66. 59–74. 45 indexed citations
12.
Sen, Triparna, et al.. (2017). A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes. Molecular Therapy — Nucleic Acids. 10. 9–27. 49 indexed citations
13.
De, Kakali, et al.. (2017). Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor. Peptides. 89. 17–34. 11 indexed citations
14.
Bharti, Rashmi, Goutam Dey, Indranil Banerjee, et al.. (2016). Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. Cancer Letters. 388. 292–302. 66 indexed citations
15.
De, Kakali, Indranil Banerjee, & Mridula Misra. (2015). Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation. Amino Acids. 47(6). 1135–1153. 11 indexed citations
16.
De, Kakali, et al.. (2014). Radiolabeled novel peptide for imaging somatostatin-receptor expressing tumor: synthesis and radiobiological evaluation. Journal of Radioanalytical and Nuclear Chemistry. 301(3). 847–861. 2 indexed citations
17.
Banerjee, Indranil, et al.. (2014). Synthesis, characterization, biodistribution and scintigraphy of 99mTc-paclitaxel: a potential tracer of paclitaxel. Journal of Radioanalytical and Nuclear Chemistry. 304(2). 633–643. 6 indexed citations
18.
Banerjee, Indranil, Kakali De, Sankha Chattopadhyay, Amal Kumar Bandyopadhyay, & Mridula Misra. (2014). An easy and effective method for radiolabelling of solid lipid nanoparticles. Journal of Radioanalytical and Nuclear Chemistry. 302(2). 837–843. 12 indexed citations
19.
20.
De, Kakali, Arijit Bhowmik, Ashok Behera, et al.. (2012). Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor‐positive tumor scintigraphy. Journal of Peptide Science. 18(12). 720–730. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thangirala Sudha Breakdown of academic impact, for papers by Anabel Sorolla Breakdown of academic impact, for papers by Ying Xie Breakdown of academic impact, for papers by Abdullah Farooque Breakdown of academic impact, for papers by Longzhu Piao Breakdown of academic impact, for papers by Leiming Xu Breakdown of academic impact, for papers by Sanam Sadreddini Breakdown of academic impact, for papers by Yong-Qiu Mao Breakdown of academic impact, for papers by Lili He
Rankless by CCL
2026